Endotracheal Intubation: Is It Time to Rethink the Gold Standard?
"Emerging research questions the long-held belief that endotracheal intubation is always the best approach to airway management. Discover why supraglottic devices are gaining traction and what this means for patient care."
Endotracheal intubation has long been considered the gold standard for advanced airway management, particularly in emergency situations and for patients requiring ventilation. The procedure involves inserting a tube into the trachea to ensure a secure and patent airway, allowing for controlled ventilation and protection against aspiration.
However, recent research is prompting a re-evaluation of this long-held belief. Studies are increasingly highlighting the potential benefits of supraglottic airway devices (SGAs) as effective alternatives, especially in certain scenarios. These devices, which are easier and faster to insert than endotracheal tubes, are challenging the conventional wisdom surrounding airway management.
This article explores the evolving landscape of airway management, examining the evidence that supports the use of supraglottic devices and questioning whether endotracheal intubation should remain the default choice. We'll delve into the factors driving this shift, the implications for patient care, and what this means for medical professionals involved in airway management.
The Scale and Safety of Emergency Intubation
More than 400,000 endotracheal intubations are estimated to be performed each year in U.S. emergency departments. Emergency airway management has advanced over the past three decades, including the development of video laryngoscopy and the use of different rapid-sequence intubation medications. The 2024 NEMSQA airway measures include respiratory assessment, oxygen for hypoxia, capnography for airway confirmation, and prevention of peri-intubation hypoxia and hypotension.
From Airway Risk to a Stable Airway
The pre-endotracheal-intubation era was marked by risks of airway obstruction and aspiration, which contributed to serious morbidity and mortality. The cited history chapter describes endotracheal intubation as a milestone in airway management’s stability, reliability, and safety. Modern endotracheal tubes are airway-protective devices that allow passage of a range of gases in medical and surgical settings. Franz Kuhn is credited with popularizing orotracheal intubation for anesthesia in the early 20th century.
The Rise of Supraglottic Airway Devices: Challenging the Status Quo
Supraglottic airway devices (SGAs) represent a diverse group of tools designed to establish an airway without requiring direct visualization of the vocal cords. Unlike endotracheal intubation, SGAs are typically inserted blindly, making them faster and easier to use, especially in emergency situations where time is of the essence.
- Ease of Use: SGAs require less training and expertise compared to endotracheal intubation, making them accessible to a wider range of healthcare providers.
- Speed of Insertion: SGAs can be inserted more quickly than endotracheal tubes, which is crucial in critical situations where every second counts.
- Reduced Complications: Studies suggest that SGAs may be associated with fewer complications, such as esophageal intubation and airway trauma, compared to endotracheal intubation.
- Comparable Outcomes: Research indicates that SGAs can provide comparable ventilation and oxygenation to endotracheal intubation in many clinical scenarios.
Limits in the Evidence
A systematic review of prehospital endotracheal intubation for adult non-traumatic out-of-hospital cardiac arrest notes that a cited analysis was secondary to a trial not designed to compare advanced airway management, so its findings require interpretation in light of that limitation. Evidence comparing supraglottic airway devices and endotracheal tubes in laparoscopic surgery has also been limited by small samples and varied, sometimes controversial, surgery types; earlier studies did not compare their performance and complications in that setting. In prehospital evidence, it is unknown whether supraglottic airways were used as primary airways or whether lower survival in that group reflected failed intubation attempts, injury severity, or more challenging airways. The physiologically difficult airway is not well described, and data on management methods are very limited.
Alternative Devices and Techniques
A systematic review and meta-analysis of randomized trials in out-of-hospital cardiac arrest found that supraglottic airway use probably increases return of spontaneous circulation compared with tracheal intubation (relative risk 1.09; 95% CI, 1.02–1.15) and leads to faster airway placement by a mean of 2.5 minutes (95% CI, 1.6–3.4 minutes less). A separate study enrolled 64 adults undergoing elective surgery who were randomly allocated to awake retrograde intubation or fibreoptic intubation, with 32 in each group. Another report describes 60 elective surgical patients expected to have difficult intubation who were enrolled to study dexmedetomidine during awake slow-induction intubation. These sources address different settings and comparisons, so they do not establish one universally superior airway method.
Redefining the Approach to Airway Management
The evidence suggests that SGAs are a valuable alternative to endotracheal intubation in many clinical scenarios. While endotracheal intubation remains an important skill for healthcare providers, it may no longer be appropriate to consider it the default choice for all patients requiring airway management.
Preparation Matters Despite Predictive Limits
A 2026 BMJ review describes tracheal intubation as potentially life-saving but also associated with a high rate of complications. It notes that tools are available to assess difficulty with bag-valve-mask ventilation, intubation, and cricothyroidotomy, but that these tools currently have limited predictive value. The review covers assessment, preparation, pharmacological considerations, intubation techniques, rescue options, confirmation, and post-sedation and ventilator management, emphasizing recent literature.
Market Trends and Emerging Directions
A market report projects that the airway management market will grow from USD 1.65 billion in 2024 to USD 2.36 billion by 2032, with a projected compound annual growth rate of 4.56% over 2024–2032; it reports a 2023 valuation of USD 1.57 billion. The report says the infra-glottic product segment accounts for the largest market share. Another market source describes demand for disposable, single-use endotracheal tubes as a driver tied to patient safety and reducing hospital-acquired infection risks. These are market-source projections and trend claims, not clinical evidence that a particular device improves outcomes.
The decision of whether to use an SGA or endotracheal intubation should be based on a careful assessment of the patient's condition, the available resources, and the expertise of the healthcare provider. Factors to consider include the patient's risk of aspiration, the need for prolonged ventilation, and the presence of any anatomical abnormalities that may make endotracheal intubation difficult.
Ultimately, the goal of airway management is to provide the best possible care for the patient. By embracing new evidence and adapting our practices, we can ensure that patients receive the most appropriate and effective airway management strategies.